These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1088514)
1. Booster effect of Sabin poliomyelitis vaccine. Teplý V; Srámová H; Svandová E Bull World Health Organ; 1976; 54(6):681-4. PubMed ID: 1088514 [TBL] [Abstract][Full Text] [Related]
2. Poliomyelitis: epidemiology and prophylaxis. 5. Results of a two- and three-dose vaccination experiment. Metselaar D; McDonald K; Gemert W; van Rens MM; Muller AS Bull World Health Organ; 1977; 55(6):755-9. PubMed ID: 202418 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568 [TBL] [Abstract][Full Text] [Related]
4. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641 [TBL] [Abstract][Full Text] [Related]
5. Eradication of poliomyelitis in Cuba: a historical perspective. Más Lago P Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790 [TBL] [Abstract][Full Text] [Related]
6. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Dong DX; Hu XM; Liu WJ; Li JS; Jin YC; Tan SG; Chen TQ; Fu JZ; Niu BY; Yu HM Bull World Health Organ; 1986; 64(6):853-60. PubMed ID: 3493854 [TBL] [Abstract][Full Text] [Related]
7. [Response of revaccination against polio I in seronegative children after receiving 3 or more doses of the vaccine]. Ruiz-Gómez J; Sánchez Burgos Y; Arrayales Sandoval F; Velázquez Zúñiga C Gac Med Mex; 1977 Jan; 113(1):23-7. PubMed ID: 863152 [No Abstract] [Full Text] [Related]
8. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043 [TBL] [Abstract][Full Text] [Related]
9. [Poliomyelitis antibody registry following 6 years of systematic oral live vaccine immunization in the German Democratic Republic with poliomyelitis live vaccine according to Sabin-Tschumakov]. Belian W; Böthig B Dtsch Gesundheitsw; 1967 Apr; 22(14):659-62. PubMed ID: 5584393 [No Abstract] [Full Text] [Related]
10. [Immunity of children and adolescents to poliomyelitis before and after type 3 oral vaccination, and immunity of unvaccinated infants in the Olsztyn Province]. Rodkiewicz T; Weglińska T Przegl Epidemiol; 1972; 26(2):201-4. PubMed ID: 5070976 [No Abstract] [Full Text] [Related]
11. [Preventive poliomyelitis immunization]. Böthig B Z Arztl Fortbild (Jena); 1990; 84(8):365-7. PubMed ID: 2165712 [No Abstract] [Full Text] [Related]
12. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy. Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534 [TBL] [Abstract][Full Text] [Related]
13. [Long-term observations of dynamics of collective immunity to poliomyelitis in vaccinated children]. Seĭbil' VB; Efimova VF; Troshina LD; Ershova GA Vopr Virusol; 1978; (1):43-7. PubMed ID: 645055 [TBL] [Abstract][Full Text] [Related]
14. [On the problem of revaccination against poliomyelitis. Results of a reinfection experiment using the poliovirus type 1, strain "LSc, 2ab (Sabin)". 4 and half years following original vaccination]. Kuwert E; Posch J; Lagarie G Med Klin; 1968 May; 63(18):701-7. PubMed ID: 4305218 [No Abstract] [Full Text] [Related]
15. Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969-70: deficiencies discovered and remedies required. MacLeod DR; Ing WK; Belcourt RJ; Pearson EW; Bell JS Can Med Assoc J; 1975 Oct; 113(7):619-23. PubMed ID: 1181016 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3. Böthig B; Danes L; Dittmann S Bull World Health Organ; 1990; 68(5):597-600. PubMed ID: 1963118 [TBL] [Abstract][Full Text] [Related]
17. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857 [TBL] [Abstract][Full Text] [Related]
18. 2001 serological survey in the Czech Republic--poliomyelitis. Matyásová I; Rainetová P; Cástková J Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257 [TBL] [Abstract][Full Text] [Related]
19. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong]. Xu A Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626 [TBL] [Abstract][Full Text] [Related]
20. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan. Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]